Replies to post #43561 on OncoSec Medical Inc (ONCSQ)

[chickpea598]

Sell side or buy side analyst targets will not make much difference in my opinion if Oncosec gets PISCES trial fast track approval. Peak sales of 500 million in melanoma alone will certainly lead to a much higher share price.....likely to dwarf current price targets in the $4-$6 range. A second future approval for Oncosec in TNBC might double their overall peak revenue numbers to 1 Billion. I think Big Pharma would lick their chops for a piece of that.

Here is a link which provides information about buyside and sellside analysts jobs and key differences/similarities:

https://www.investopedia.com/articles/financialcareers/11/sell-side-buy-side-analysts.asp